UAE Deepens US Healthcare Ties in Genomics and Digital Health
UAE health officials travelled to the U.S. to strengthen collaborations in genomic medicine, digital health, and specialised care. Meetings spanned top research centres, focusing on early disease detection, AI, and workforce development. The goal is to translate U.S. expertise into UAE health syste…
By Felo News Desk · Published
The United Arab Emirates has taken a decisive step to broaden its medical collaboration with the United States, focusing on cutting‑edge areas such as genomic medicine, artificial intelligence, and specialised care. The initiative was launched during a high‑profile visit by Health Minister Ahmed Ali Al Sayegh and a delegation from Emirates Health Services (EHS) and the Department of Health – Abu Dhabi (DoH). The trip, which coincided with the 81st session of the United Nations General Assembly, saw the UAE delegation tour leading U.S. hospitals, research institutes, and academic institutions in Boston and New York.
Strategic Focus Areas
During the week‑long tour, the UAE team zeroed in on several priority themes. These included genomic medicine and early disease detection, the application of artificial intelligence (AI) in clinical workflows, digital health platforms, rare disease research, and the development of specialised care centres. A key objective was to build the UAE’s capacity to adopt advanced medical technologies and to train healthcare professionals to operate in a rapidly evolving environment.
Genomic Medicine and Early Cancer Detection
In Boston, the delegation met with the Dana‑Farber Cancer Institute to discuss a potential early cancer detection pathway that would use genomic testing. The proposed model would combine risk assessment, genetic counselling, follow‑up care, and referrals to treatment services. It would also include training for physicians and patient care coordinators in the latest precision‑medicine protocols. At Boston Children’s Hospital, the UAE team explored ways to expand cooperation in diagnosing and treating rare and complex paediatric conditions, including the creation of centres of excellence, visiting physician programmes, and joint research initiatives.
Both meetings highlighted the importance of newborn screening for genetic disorders. The UAE delegation sought to adopt best practices for confirmatory testing, specialist assessment, and therapeutic intervention for infants who test positive during routine screening.
Digital Health and Artificial Intelligence
The UAE delegation also engaged with Mass General Brigham to explore collaboration on digital health solutions, AI‑driven diagnostics, and integrated care models. Discussions covered the use of AI in cardiology, neuroscience, and oncology, as well as opportunities to share expertise in developing patient‑centric digital platforms. Minister Al Sayegh underscored the need for sustainable healthcare financing and a unified public health system that can leverage AI for better emergency preparedness.
In addition, a meeting with a vice dean from Harvard T. H. Chan School of Public Health focused on public‑health research and training, while a session with the U.S.–UAE Business Council explored broader healthcare sector cooperation.
Specialised Care and Physician Exchange
In New York, the UAE delegation visited New York‑Presbyterian, The Mount Sinai Hospital, and other leading institutions. Discussions centred on physician exchanges, training programmes, and research collaboration in paediatric cardiology, organ transplantation, gene therapy, oncology, and proton therapy. The delegation also met with representatives from Children’s Hospital of Philadelphia, Cedars‑Sinai, Penn Medicine, and Johnson & Johnson to discuss potential joint initiatives and leadership training programmes in partnership with Johns Hopkins.
Parallel to the official meetings, the EHS delegation met with Northwell Health and NYU Langone Health to explore cooperation in neuroscience, cardiology, medical device development, and digital health. These meetings were aimed at establishing visiting physician programmes and sharing best practices in executive health screening and patient care.
Next Steps and Implementation
Following the visits, the UAE Ministry of Health and Prevention (MoHAP) has announced that it will work closely with each U.S. partner to develop concrete action plans. These plans will outline priorities, responsibilities, and implementation timelines to ensure that the identified areas of cooperation translate into tangible improvements in the UAE’s health system.
By fostering these international partnerships, the UAE aims to accelerate the adoption of scientific and technological advances, strengthen prevention‑focused care, and ultimately improve health outcomes for its population.
As the UAE continues to invest in healthcare innovation, these collaborations signal a broader commitment to building a resilient, future‑ready health system that can keep pace with rapid global developments.
Key facts
- UAE health minister visits U.S. to boost genomic medicine and AI collaborations
- Meetings held with top U.S. hospitals and research institutions in Boston and New York
- Focus on early cancer detection, rare disease research, and specialised care centres
- Plans to develop joint training and leadership programmes for UAE healthcare professionals
- Commitment to translate cooperation into actionable improvement plans
Why it matters
The partnership enhances the UAE’s access to world‑class genomic and AI technologies, positioning the country to deliver more precise, preventive, and high‑quality care to its citizens.
Frequently asked questions
What are the main goals of the UAE’s visit to the U.S. health sector?
The visit aims to strengthen partnerships in genomic medicine, digital health, AI, and specialised care, and to develop joint training and research programmes that can be implemented in the UAE.
Which U.S. institutions did the UAE delegation meet with?
Key institutions included Dana‑Farber Cancer Institute, Boston Children’s Hospital, Mass General Brigham, New York‑Presbyterian, The Mount Sinai Hospital, Children’s Hospital of Philadelphia, Cedars‑Sinai, Penn Medicine, Johnson & Johnson, Northwell Health, and NYU Langone Health.
Sources
- [1] gulfnews.com — originally reported as “UAE Strengthens US Healthcare Partnerships in Genomic Medicine, Digital Health and Specialised Care”
